Cold Genesys coldgenesys.com


Public list: Pharma Startups (4729) Cancer Therapeutics (1129)

Cold Genesys is a clinical-stage immuno-oncology company focused on the development of oncolytic immunotherapies to combat cancer. In 2010, Cold Genesys acquired exclusive worldwide rights to develop CG0070 from BioSante Pharmaceuticals. CG0070 is currently under investigation in a Phase II, single-arm, open-label, pivotal study (BOND II) for patients with high-risk non-muscle invasive bladder cancer (NMIBC) who have failed BCG therapy and refused cystectomy. In addition, Cold Genesys is explori...Show all

Cold Genesys is a clinical-stage immuno-oncology company focused on the development of oncolytic immunotherapies to combat cancer. In 2010, Cold Genesys acquired exclusive worldwide rights to develop CG0070 from BioSante Pharmaceuticals. CG0070 is cu...Show all

Company (Alive / Active)

Phone: 949-288-6298

Fax:

6 Hutton Centre Drive
Suite #1220
Santa Ana, 92702
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Cold Genesys $23.6M Aug 5, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Cold Genesys Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
WI Harper GroupVenture CapitalSan Francisco, California, United StatesSeries B
Ally Bridge GroupVenture CapitalHong KongSeries B, Series A
Song Hang FangAngel Investor (Individual)Series B
Whitesun Healthcare VenturesVenture CapitalSeries B
See all 4 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Adenovirus vectors containing cell status-specific response elements and methods of use thereof Aug 20, 2007 Jun 28, 2011 Patent
Adenovirus vectors containing cell status-specific response elements and methods of use thereof Jul 29, 2008 May 17, 2011 Patent